🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Koch

Cambridge Quantum Computing (United Kingdom)

ORCID: 0000-0001-8511-2703
EngineeringMedicineEconomics, Econometrics and FinanceComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Screening for Colorectal Cancer in a Safety-Net Health Care System: Access to Care Is Critical and Has Implications for Screening Policy

(2023)10.1158/1055-9965.c.6514774.v1
Top 100%
0DataRank
Top 100%0 citations

Liyue Tong, James E. Allison, Elizabeth Carter, Mark Koch, Don C. Rockey +5 more

Papers

Driven by 3 papers — median percentile 0. Top paper: “Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons”.

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Clinical Infectious Diseases(2024)10.1093/cid/ciae010
N/A
4.1DataRank · unranked
164 citations

Alberto Papi, Eugene Athan, Robert G. Feldman, Joanne M. Langley, Dong‐Gun Lee +95 more

Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00048-7
N/A
1.2DataRank · unranked
58 citations

Alberto Papi, Eugene Athan, Robert G. Feldman, Joanne M. Langley, Dong‐Gun Lee +95 more

Data from Screening for Colorectal Cancer in a Safety-Net Health Care System: Access to Care Is Critical and Has Implications for Screening Policy

(2023)10.1158/1055-9965.c.6514774.v1
Top 100%
0DataRank
Top 100%0 citations

Liyue Tong, James E. Allison, Elizabeth Carter, Mark Koch, Don C. Rockey +5 more